NCT01030016 is a Phase 4 clinical trial of atenolol in Blood Pressure, sponsored by University of Sao Paulo.

Who is sponsoring NCT01030016?

NCT01030016 is sponsored by University of Sao Paulo.

What drugs are being tested in NCT01030016?

Interventions in NCT01030016: atenolol.

What condition does NCT01030016 study?

NCT01030016 studies Blood Pressure, Exercise.

Is NCT01030016 still recruiting?

NCT01030016 is currently completed. Last updated 14 December 2009.

Last reviewed 2009-12-14 · How we verify

NCT01030016

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Blood Pressure Response During Resistance Exercise in Hypertensives: Influence of Beta-blockers

Completed Phase 4 Last updated 14 December 2009

What this trial tests

Phase 4 trial testing atenolol in Blood Pressure in 10 participants. Completed in 1 May 2009.

Timeline

1 May 2007

Primary endpoint
1 May 2009

1 May 2009

Quick facts

Lead sponsor	University of Sao Paulo
Phase	Phase 4
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	crossover
Masking	single
Primary purpose	supportive care
Enrollment	10
Start date	1 May 2007
Primary completion	1 May 2009
Estimated completion	1 May 2009
Sites	1 location across Brazil

Drugs / interventions tested

atenolol (ATENOLOL) — full drug profile →

Conditions studied

Blood Pressure — all drugs for Blood Pressure →
Exercise — all drugs for Exercise →

Sponsor

University of Sao Paulo

Who can join

Adults 30 to 60, any sex, with Blood Pressure or Exercise. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

blood pressure during resistance exercise
Time frame: 6 weeks

Sponsor's own description

The study was designed to investigate if atenolol is able to blunt blood pressure increase during resistance exercise in hypertensive subjects.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of atenolol

Trials testing the same drug.

NCT07268170 — Heart Rate Control Before Cardiac Computed Tomography in Adults for the Evaluation of Coronary Artery Disease · Phase 2, PHASE3 · enrolling by invitation

Other recruiting trials for Blood Pressure

Currently open trials in the same condition.

NCT07070583 — Impact of Aorto-Iliac Occlusive Disease Treatment on Blood Pressure · NA · recruiting
NCT07396636 — Machine Learning-Assisted Management of Intraoperative Hypotension for Personalized Treatment · recruiting
NCT06719518 — Performance Evaluation of the ViTrack Continuous Non-invasive Blood Pressure Measurement Device · recruiting
NCT07319117 — Evaluation of the Impact of a Nutritional Formulation on Cognitive Performance Following Stress Exposure. · NA · recruiting
NCT06837181 — Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM) · recruiting

Other University of Sao Paulo trials

Trials by the same sponsor.

NCT07463859 — Effects of Periodontal Treatment Associated With Antimicrobial Photodynamic Therapy on Halitosis in Patients With Diabet · NA · recruiting
NCT07522554 — Lavender and Lemongrass Aromatherapy for Pain and Anxiety in Labor: A Randomized Trial · NA · active not recruiting
NCT07479940 — Obesity and Aging: Impacts of Nutritional Counseling and Physical Exercise on Telomeres and Senescence Parameters · NA · active not recruiting
NCT07445178 — Piecemeal Resection and Advanced Histology Independently Predict Local Recurrence After Colorectal Snare-based Endoscopi · completed
NCT07170007 — Physiotherapeutic Protocol Compared to Usual Care in the Treatment of Primiparas After Perineal Trauma · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01030016 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Sao Paulo
Last refreshed: 14 December 2009

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01030016.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing